Gland Pharma Limited

NSE: GLAND

Healthcare Healthcare

₹2,247.8

-1.11%EOD · 8 Jun

Gland Pharma Limited is a listed Healthcare company on NSE/BSE. Detailed profile data is being compiled — check BSE filings for the latest disclosures.

Market Cap

₹37,080 Cr

52W Range

₹2396 / ₹1574

Volume

474K

32.4% delivery

1Y Return

+33.0%

P/E Ratio

36.5

P/B Ratio

3.6

ROE

10.5%

Debt / Equity

2.74

Peers in Healthcare

Top 8 by market cap

Company	LTP	Market Cap	P/E	P/B	ROE %	Div Yld %
Gland Pharma Limited(this stock)	₹2,247.8	₹37,080 Cr	36.5	3.6	10.5%	0.88%
Divi's Laboratories LimitedDIVISLAB	₹6,521	₹1.73 L Cr	68.5	10.5	16.2%	0.45%
Torrent Pharmaceuticals LimitedTORNTPHARM	₹4,410.4	₹1.49 L Cr	69.0	17.7	17.0%	0.86%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP	₹8,358.5	₹1.20 L Cr	61.4	12.6	21.5%	0.24%
Zydus Lifesciences LimitedZYDUSLIFE	₹1,087.6	₹1.09 L Cr	21.7	4.3	18.3%	0.09%
Max Healthcare Institute LimitedMAXHEALTH	₹1,007.45	₹98,049 Cr	66.2	8.8	14.3%	0.15%
Mankind Pharma LimitedMANKIND	₹2,357.4	₹97,339 Cr	50.5	6.3	12.4%	0.09%
Aurobindo Pharma LimitedAUROPHARMA	₹1,451.8	₹83,533 Cr	24.2	2.2	9.9%	0.27%
Laurus Labs LimitedLAURUSLABS	₹1,404.7	₹75,889 Cr	92.6	14.7	17.7%	0.17%

Technical Indicators

Full analysis · objective math, not advice

Returns

-1.1%

-1.3%

+18.4%

+31.7%

+32.3%

+33.0%

Weinstein Stage

Stage 2 — Advancing (uptrend)

RSI (14)

35 Neutral

Trend Template

5/7moderate

Moving Averages (price vs MA)

20-DMA

₹2254

below

50-DMA

₹1965

above

150-DMA

₹1820

above

200-DMA

₹1850

above

From 52W High

-6.2%

From 52W Low

+42.8%

Support (20D)

₹1854

Resistance (20D)

₹2396

Technical indicators are objective calculations from historical EOD prices (RSI, moving averages, Weinstein stage, Minervini trend-template, relative strength). For educational reference only — not a buy/sell recommendation.

News & FilingsGoogle News + BSE

News via Google News · Not verified by IPOpulse · Not investment advice

Community discussion(0)

No comments yet — be the first to share your view.